nabu.science
MethodologyAboutContact

 

  • Snapshot
  • Key Claims
  • Strengths & Limitations
  • Commentary
  • From the Authors
  • Author Note / Field Feedback
  • Dimension breakdown
  • Impact Profile
Free · About 5 minutes
Report #NBU-9698E4D1·Framework v5.7-cal·Pipeline v0.4·Evaluated 10 Aug 2026·OECD: 3.2 Clinical medicine·Subfield: Reproductive Medicine·Basis: Full text·Type: Narrative review

The Global Decline in Sperm Count and Testosterone Levels: Trends, Mechanisms, and Environmental Drivers

Sandro La Vignera et al.Sandro La Vignera, Rosita A. Condorelli·2026·Antioxidants·10.3390/antiox15060778 ↗

Primary claim

Sperm concentration declined by 51.6% globally between 1973 and 2018, with an accelerating trajectory post-2000 (from 1.16% to 2.64% per year).

Supported · drawn from Levine meta-analyses, with heterogeneity and countertrend evidence limiting certainty
In brief

A broad male-reproductive-health synthesis with clinical reach, constrained by selective engagement with counterevidence and no source-selection method.

ReliabilityCaveats4 of 4 checks completeRead the entry ↓
Abstract

Male reproductive health has experienced an unprecedented decline over the past five decades, characterized by substantial reductions in sperm count and testosterone levels. This review provides a comprehensive synthesis of current evidence on the global decline in sperm count and testosterone levels, examining epidemiological trends, underlying mechanisms, environmental drivers, and clinical implications. Sperm concentration declined by 51.6% globally between 1973 and 2018, with an accelerating trajectory post-2000 (from 1.16% to 2.64% per year). Concurrently, multiple independent studies document an age-independent secular decline in testosterone, averaging 1-2% per year across diverse populations. The etiology is multifactorial, involving endocrine-disrupting chemicals (bisphenol A, phthalates, pesticides, dioxins), lifestyle factors (obesity, sedentary behavior, smoking, heat exposure), and disruption of the hypothalamic-pituitary-gonadal axis. At the cellular level, mechanisms include Sertoli and Leydig cell dysfunction, oxidative stress, mitochondrial impairment, and sperm DNA fragmentation. Integrated clinical management combining lifestyle optimization, antioxidant therapy, and targeted endocrine interventions is essential. Prevention through environmental policy and public health initiatives represents the most promising long-term strategy.

Key Claims

Primary finding · Supported

Sperm concentration declined by 51.6% globally between 1973 and 2018, with an accelerating trajectory post-2000 (from 1.16% to 2.64% per year).

drawn from Levine meta-analyses, with heterogeneity and countertrend evidence limiting certainty

Abstract; §2.1–§2.3
Secondary · Supported

multiple independent studies document an age-independent secular decline in testosterone, averaging 1–2% per year across diverse populations.

multiple cohort and population studies are cited, though methodological debate is not fully engaged

Abstract; §3.1
Secondary · Tentative

The etiology is multifactorial, involving endocrine-disrupting chemicals, lifestyle factors, and disruption of the hypothalamic–pituitary–gonadal axis.

mechanistic plausibility and associations are extensive, but causal inference remains limited

Abstract; §4–§6
Secondary · Tentative

Integrated clinical management combining lifestyle optimization, antioxidant therapy, and targeted endocrine interventions is essential.

clinical options are summarized, but comparative effectiveness and implementation evidence are limited

Abstract; §7
Secondary · Tentative

Prevention through environmental policy and public health initiatives represents the most promising long-term strategy.

policy direction is plausible but not established by intervention or comparative policy evidence

Abstract; §8 Conclusions

Derived from the full evaluation — not a separate score.

Strengths · Limitations

Strengths

#contribution

Broad integration across linked literatures

The article brings together sperm-count trends, testosterone decline, environmental exposures, cellular mechanisms, and clinical implications in one review. This breadth makes it useful as an orientation document for readers entering the topic.

↳ Abstract; §2–§7

#methodological rigour

Substantive causal-limitations discussion

Section 5.5 explicitly distinguishes association and biological plausibility from established causation for endocrine-disrupting chemicals. It discusses cross-sectional designs, confounding, mixture exposure, animal-to-human extrapolation, and exposure measurement uncertainty.

↳ §5.5 Limitations of the Evidence

#application pathway

Clear clinical pathway summary

The clinical section covers diagnostic evaluation, lifestyle interventions, antioxidant therapy, endocrine treatment, and assisted reproductive technologies. The guidance is not new evidence, but it gives clinicians a structured map of existing options.

↳ §7 Clinical Implications and Therapeutic Perspectives

Limitations

#methodological rigour

No transparent source-selection method

The article does not report databases searched, date ranges, inclusion or exclusion criteria, or how evidence was selected. That limits assessability for a narrative review making broad claims about global trends and environmental drivers.

↳ Introduction; full text methods absence

#positioning

Counterevidence receives limited integration

Section 2.2 notes complex Chinese trends and a fertile-men study with no significant temporal trends, but these findings are treated briefly rather than used to substantially qualify the global-decline narrative. This weakens the contextual balance around the article’s headline claim.

↳ §2.2 Geographic Variations and Regional Patterns

#reporting

Crisis framing outruns causal evidence

The abstract and conclusions frame the issue as an unprecedented crisis requiring urgent policy action, while §5.5 states that EDC associations should be interpreted as biologically plausible rather than causal. The mismatch affects how strongly readers should take the article’s policy and etiologic claims.

↳ Abstract; §5.5; §8 Conclusions

Does this match your read? Add your assessment ↓

Nabu Commentary

The article’s strongest feature is its breadth: it links population trends, HPG-axis biology, EDC mechanisms, lifestyle exposures, and clinical management in a single narrative. Section 5.5 improves the review by explicitly warning that much of the EDC literature supports biological plausibility rather than causal certainty. The absence of a source-selection method limits confidence in how completely and evenhandedly the literature was assembled. The article also acknowledges contrary trend findings in §2.2 but does not fully integrate them into its conclusion that male reproductive decline is a global public health crisis.

Evaluate another paper

Free · About 5 minutes · Research preview

Author Note / Field Feedback

Nabu’s assessment, alongside the field’s view.

Are you an author of this paper?

Dimension breakdown

Evidence Score

Out of 5
012345
3.0±0.1

Contribution
3.0

The article contributes a broad synthesis linking sperm-count trends, testosterone trends, mechanisms, environmental exposures, and clinical implications, but its advance is primarily integrative. It does not provide new empirical evidence, a transparent synthesis method, or a framework that resolves the field’s causal and measurement uncertainties.

Abstract; Introduction; §8 Conclusions

This review provides a comprehensive synthesis of current evidence

Methodological Rigour
3.1

The article is organized in a coherent sequence from epidemiology to mechanisms, exposures, and clinical implications, and §5.5 offers a real causal-inference caveat for EDC evidence. Methodological Rigour is limited by the absence of any search or source-selection method for a narrative review making broad empirical claims.

§2–§7; §5.5 Limitations of the Evidence

associations...should be interpreted as suggestive of biological plausibility

Reporting
3.2

The prose is followable and the structure is easy to track, with a nomenclature section that helps define technical terms. The score is capped because the abstract and conclusions use crisis-level and policy-imperative language that is stronger than the article’s own limitations discussion supports.

Abstract; §5.5; §8 Conclusions

one of the most significant and underappreciated public health challenges

Positioning
2.7

The review cites major prior work, including Carlsen, Levine, testosterone trend studies, and recent mechanistic literature. Positioning is constrained because contrary or complicating trend evidence is acknowledged briefly but not used to temper the central global-decline narrative in a sustained way.

§2.1–§2.2; §3; §5.5

some regions have shown stable or even increasing sperm counts

Lower confidence on Methodological Rigour, Positioning — domain match limited.

Reliability

Caveats4 of 4 checks


Internal CoherenceNoted

The article is numerically coherent on its headline trend claims, but the figure captions/content and one figure citation create traceability issues. These are editorial and attribution problems rather than evidence of impossible statistics or a methods-results contradiction.

Research ConductClean

The article is a narrative review and appropriately states that IRB approval, informed consent, and data sharing are not applicable because no new data were created or analyzed. Funding is declared as none, and ChatGPT-4 use for language editing and schematic figures is disclosed with author responsibility stated.

Flags: 1 declared / 5 total

Reference IntegrityClean

75 of 75 checkable references verified

76 references in manuscript 1 have no canonical index record — counted, but not index-checkable 1 reference confirmed by manual review

References not verified automatically are resolved manually within 24 hours.

Post-Publication RecordClean

No retraction or expression of concern found in Crossref (includes Retraction Watch).

Last checked: 17 Oct 2026

Sources: Crossref (incl. Retraction Watch) ✓

Impact Profile

Impact areaHealth · Renal and urogenital · Urinary diseases and male infertility
Type of advanceSynthesis
Route to useSpecified
AdvanceConsolidates
BeneficiariesMedium
CitationsToo early
Policy · patentNot yet traced
ReachedNot reachedNot assessable or unverified
ReadinessValidated
Foundational
Controlled
Piloted
Validated
Implementable
FoundationalImplementable

The primary claim rests on published meta-analyses of 223 studies of real-world population semen data spanning continents, confirming the trend in an independent and broader setting.

From the paper
“Clinical practice must evolve to address this crisis: clinicians should routinely assess environmental and occupational exposures, provide evidence-based lifestyle counseling”

The conclusion names clinicians as the actors and specifies the setting (clinical practice), the decisions (routine exposure assessment, lifestyle counseling, advanced semen testing) and how they would apply them.

Pathway

Policymakers would tighten regulation of endocrine-disrupting chemicals while clinicians expand exposure assessment and advanced semen testing in fertility care.

Barrier

Most human evidence is observational and cross-sectional, so causal links between endocrine disruptors and reproductive decline remain unproven, weakening policy justification.

Evaluated 13 Nov 2026 · GBD 2023 · glm_v1_3_3 · impact_profile_v1_3_3

Report an issue →

AI-generated, human-governed. Something look off? Contact us to request a review.

Keep reading

Related evaluations

Other papers Nabu has evaluated blind, starting with the same field.

  1. Sperm intrusion into the implantation-stage blastocyst and its potential biological significance

    Sengupta, Kroneis, Boddy, et al. · 2023 · Biological sciences

    Primary claim

    Fig. 1 displays transmission electron microscopic evidence of sperm embedded in the cytoplasm of trophectoderm cells of zona-free blastocysts retrieved during the peri-implantation stage from three rhesus monkeys during their natural pregnancies.

    Supported
    Evidence Score
    3.0±0.2
    Reliability
    Caveats
  2. On-premise medical AI agents for reliable clinical decision-making

    2026 · Clinical medicine

    Primary claim

    Diagnostic behavioral consistency provided the strongest discrimination of correctness (area under the curve (AUC) = 0.860) and remained informative under stress testing (AUC = 0.875).

    Supported
    Evidence Score
    3.7±0.2
    Reliability
    Caveats
  3. Retatrutide in adults with obesity and type 2 diabetes (TRIUMPH-2): a double-blind, parallel-group, randomised, placebo-controlled, phase 3 trial

    2026 · Clinical medicine

    Primary claim

    In adults with obesity and type 2 diabetes, once-weekly retatrutide over 80 weeks produced weight reduction of up to 18·8% from baseline with an estimated treatment difference of -13·8% versus placebo

    Well-supported
    Evidence Score
    4.2±0.1
    Reliability
    No concerns

How the rubric works →